New editorial exposes big problems with the clin epi/EBM methods community losing our bearings in balancing simplicity vs methods sophistication. Excessive complexity includes Cochrane RoB 2, ROBINS-I, and GRADE methods. Solutions are on the way! pubmed.ncbi.nlm.nih.gov/38453419/

You beat me to it Wen Jiang MD, PhD #4AMTwitter
Awesome to work with Nature Biomedical Engineering
We are so proud of you DaeYong Lee
This is all you: concept +hard work!
#endcancer #teamwork MD Anderson Cancer Center

Story-led Causal Inference. Young, Jessica G. Epidemiology. journals.lww.com/epidem/fulltex…

Outstanding summary. Thanks for sharing!

Variance estimation for reference-based multiple imputation – the debate continues thestatsgeek.com/2024/04/18/var… Suzie Cro Tim Morris

Humbled and honored to be part of this illustrious group. Can’t do it without great mentors joeltepper Robert Langer Samuel Achilefu support and my better half’s support Tian Zhang, MD, MHS

Excited to share our latest work ⁦Nature Biomedical Engineering⁩ with ⁦Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE⁩ describing a new way to engineer polypeptides to enhance immune responses in innate immune cells for #cancerimmunotherapy ⁦MD Anderson Cancer Center⁩ ⁦Albert Koong, MD PhD⁩ 1/n nature.com/articles/s4155…

Sarcomatoid features are the ‘end of the line’ in all RCC. The pathologist approach to classifying RCC. #IKCSEU24

Lisa Pickering 💉💙 announcing the Kidney Cancer Pieter De Mulder Award Winner 2024 to Manuela Schmidinger. What a champion and inspiration for all patients and colleagues! KCCure Michael Staehler B.C. Leibovich MD Gretchen Vaughan Yüksel Ürün Pavlos Msaouel Tian Zhang, MD, MHS

“The shame of modern science is that everyone is hyperfocused on their system, their approach, their organism, their discipline. It can stifle innovation when people are not broadly trained and don’t step outside their comfort zone.” quantamagazine.org/pleasure-or-pa…

Our manuscript on the priorities of older patients regarding outcomes in cancer care is out in ACS Journal Cancer.
Here , we studied which outcomes were more important for older adults starting chemo. #gerionc City of Hope Conquer Cancer, the ASCO Foundation
FREE here ⬇️
doi.org/10.1002/cncr.3…

5-year review of 'abandon significance': 'Don't let the tail wag the dog' errorstatistics.com/2024/04/17/5-y…

Do research articles have to be so one-sided?
statmodeling.stat.columbia.edu/2024/04/17/do-…

Von Hippel Lindau tumor suppressor controls m6A-dependent gene expression in renal tumorigenesis: buff.ly/3JnBeGf

Qing Zhang UT Southwestern Medical Center
#Oncology

#Statistics thought of the day: The Wilcoxon test assumes more than the proportional odds ordinal logistic model, and unlike the PO model does not provide estimates of exceedance probabilities, means, and quantiles. fharrell.com/post/rpo fharrell.com/post/powilcoxon Vanderbilt Department of Biostatistics

What are the challenges with diagnosing #RenalMedullaryCarcinoma ? Dr. Nizar Tannir from
MD Anderson Cancer Center via Patient Empowerment Network explains: bit.ly/3U4gjwF #RMC ,   #kidneycancer
R.M.C. Inc KidneyCAN Chris Johnson Foundation Inc. RMC Alliance @KidneyCanc KCCure

Dr. Goswami's Oncology Journey: Patient-centric Science and Mentorship Stories ⁦MD Anderson Cancer Center⁩ ⁦OncLive.com⁩ onclive.com/view/dr-goswam…

Interested in #ferroptosis and #ProstateCancer ?……..check out our new work in Nature Reviews Urology discussing the regulation & role of this process in the context of PCa. This was led by the great Nikki Cao and Ela Subramani from the lab.
MD Anderson Cancer Center CDMRP

As part of National Cancer Prevention and Early Detection Month, National Cancer Institute is dedicated to the #CancerMoonshot goal to prevent more cancers before they start + detect cancer early, when it’s most treatable. The #NationalCancerPlan helps guide these efforts. nationalcancerplan.cancer.gov/goals